CANOCAPAVIR

UNII:	ITF8H4SZR1
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₇H₂₁BrFN₅O₃
Preferred Substance Name:	CANOCAPAVIR
InChIKey:	YGPZZDKSASSELG-AREMUKBSSA-N
GSRS Full Record:	ITF8H4SZR1 i

2137847-19-7
(2R)-2-[1-(4-bromophenyl)-3-(4-fluorophenyl)pyrazol-4-yl]-3-[2-(2-oxo-1,3-dihydrobenzimidazol-5-yl)ethyl]-1,3-oxazolidin-4-one
2H-BENZIMIDAZOL-2-ONE, 5-(2-((2R)-2-(1-(4-BROMOPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL)-4-OXO-3-OXAZOLIDINYL)ETHYL)-1,3-DIHYDRO-
5-(2-{(2R)-2-[1-(4-bromophenyl)-3-(4-fluorophenyl)-1Hpyrazol- 4-yl]-4-oxo-1,3-oxazolidin-3-yl}ethyl)-1,3- dihydro-2H-benzimidazol-2-one
5-[2-[(2R)-2-[1-(4-Bromophenyl)-3-(4-fluorophenyl)-1H-pyrazol-4-yl]-4-oxo-3-oxazolidinyl]ethyl]-1,3-dihydro-2H-benzimidazol-2-one
Canocapavir
Canocapavir [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CANOCAPAVIR

Synonyms and Mappings

Resources